宜宾哪双眼皮做的好宜宾有哪家祛斑医院,宜宾隆鼻隆鼻那里好,宜宾医院割双眼皮保持时间,宜宾用激光脱毛能绝毛吗,宜宾有哪些正规知名整形美容医院,宜宾专业隆鼻子,宜宾双眼皮修复哪家好

SYDNEY, Aug. 2 (Xinhua) -- Australia's general practitioners ( GPs) will not back the idea of routine prostate cancer tests for men as young as 40 despite growing calls for regular screening, the nation's largest professional general practice organization said on Tuesday.Spokesman for the Royal Australian College of General Practitioners (RACGP), Professor Chris Del Mar said there was not enough solid evidence to suggest major benefits from routine screening and that current tests were unable to detect "nasty" and potentially deadly forms of prostate cancer from ones that will not cause any harm."The problem is you end up treating lots of people who don't need to be treated," Del Mar said, adding that treatment could leave men impotent and with incontinence problems."You will treat 20 times as many people than would have ever been bothered by it. We don't yet know that treating prostate cancer is better than not treating it. We are not sure it does any good and could be doing more harm," he said.On the other hand, Australia's urologists and pathologists both want men aged 40 and over who are worried about developing the disease to be offered tests.The Royal College of Pathologists (RCPA) on Tuesday released an official recommendation on routine screening for men aged 40 and over if they were concerned about prostate cancer.The pathologists argue that blood tests for prostate cancer in men under 50 can predict their future risk of developing the disease by measuring their prostate specific antigen levels (PSA).They say that men with high PSA levels for their age should be tested annually, while those PSA levels are below the average could be tested less frequently.Their call for more routine testing contrasts with recommendations for GPs, whose `Red Book' medical guide does not support regular screening.Instead, it suggests GPs should inform men aged 50-70 of the risks and benefits of screening and only test if the patient requests one.RACGP spokesman Del Mar, who co-wrote the RACGP's recommendations, said while the Red Book was being revised "we are not going to liberalize it".Prostate cancer is one of the most common forms of cancer in Australia.About 20,000 cases of prostate cancer are diagnosed each year, with 3,300 men dying.Given the debate around prostate cancer tests, the Royal College of Pathologists wants to work with GPs, urologists and other medical organizations to develop a consensus on how and when to test for the disease, in a similar way to how experts approach breast cancer."It would be a good outcome for prostate cancer if we worked towards developing more of an umbrella document which reflected consensus among different stakeholder organizations. ," RCPA President Paul McKenzie said.

BEIJING, June 27 (Xinhuanet) -- A lost tribe has been spotted in the Amazon rainforests of Brazil, according to the media report Monday.The discovery was confirmed by National Indian Foundation (FUNAI) of Brazil, a government body overseeing indigenous peoples.The tribe was initially found through satellite images earlier this year and later confirmed by the observers in aerial fight over the area.There are approximately 200 members in this isolate community who share three straw-roofed buildings and make their living from growing corns, bananas and other crops.FUNAI does not contact with the new-found tribe or give its exact location in order to protect its life from being disturbed."Among the main threats to the well-being of these groups are illegal fishing, hunting, logging, mining, cattle ranching and drug trafficking," FUNAI coordinator Fabricio Amorim warned."The work of identifying and protecting isolated groups is part of Brazilian public policy," he said, and "to confirm something like this takes years of methodical work."

WASHINGTON, Sept. 13 (Xinhua) -- The U.S. Department of Health and Human Services (HHS), with several partners, on Tuesday launched Million Hearts, an initiative that aims to prevent one million heart attacks and strokes over the next five years.The program will focus on helping Americans make healthy choices, such as preventing tobacco use and lowering consumption of salt and trans fats, and increasing use of treatments like aspirin and blood pressure and cholesterol-lowering medications.The HHS hopes that by 2017, 65 percent of high-risk patients will be taking aspirin and have their blood pressure and cholesterol under control. Currently, only 47 percent of high-risk patients take aspirin, and only 33 percent have their cholesterol and 46 percent their blood pressure under control.They also aim to cut smoking to 17 percent of Americans from 19 percent by 2017, and seek a 20 percent drop in sodium intake and a 50 percent drop in trans fat consumption."Heart disease causes one of every three American deaths and constitutes 17-percent of overall national health spending," said HHS Secretary Kathleen Sebelius in a statement. "By enlisting partners from across the health sector, Million Hearts will create a national focus on combating heart disease."

BEIJING, Aug. 2 (Xinhuanet) -- The first close-up pictures of the asteroid Vesta, a protoplanet that dates back to the early days of the solar system, were revealed Monday by NASA scientists.The images were taken by the U.S. space agency's Dawn robotic probe, which is two weeks into a planned year-long survey of the second largest object in the main asteroid belt, located between Mars and Jupiter.About twice the size of California, Vesta is second in size only to Ceres, Dawn's next target and, along with Pluto, one of just five known dwarf planets. NASA is spending 466 million dollars to explore Vesta and Ceres during the course of a 10-year mission.Images from Dawn show Vesta a surprisingly diverse terrain and several unexplained geologic features. Chaotic terrain near the south pole is dominated by a towering central peak and huge ripple-like grooves stretching around its equatorial belt. Bright spots, dark pits and craters are filled with unexplained streaks of black and white debris. Terrain north of the grooves is much more heavily cratered.Scientists believe Vesta grew from a clump of gas and dust left over after the sun's birth some 4.65 billion years ago, a supernova explosion, which added radioactive materials to the growing body.Dawn will spend about a year circling Vesta, tweaking its orbit and altitude using an innovative technology called ion propulsion system, chief engineer Marc Rayman with NASA's Jet Propulsion Laboratory in California said.The ion propulsion system will enable Dawn to leave Vesta's orbit after a year of study and head off to Ceres, which is the largest object in the asteroid belt.

WASHINGTON, Aug. 4 (Xinhua) -- U.S. scientists have found two gene mutations occurring in oligodendrogliomas, the second-most common form of brain cancer, according to a study to be published Friday in journal Science.For years scientists have been looking for the primary cancer genes involved in oligodendrogliomas evolvement. Scientists know the two chromosomes held the probable mutations, but the particular gene information remains unclear.Now scientists at Duke University Medical Center and Johns Hopkins University have discovered the most likely genetic mutations that researchers have been hunting for on chromosomes 1 and 19.The genes they identified, CIC or FUBP1, are tumor suppressor genes. The cancer-related pathways that involve these genes could become targets for future treatments, said Hai Yan, a Duke associate professor of pathology and co-corresponding author of the study.The researchers found CIC on chromosome 19 and FUBP1 on chromosome 1 based on an initial study of seven oligodendrogliomas. They found six mutations and two mutations, respectively, in the seven tumors. Further study of 27 more of these tumors showed that there were 12 and three mutations of CIC and FUBP1, respectively. The two genes were rarely mutated in other types of cancers, indicating that they are oligodendroglioma-specific genes.These genes were difficult to find until the technology improved, said Yan."The team used whole genome sequencing technology so that no genes would be excluded, and we found to our surprise that one gene, on chromosome 19, was mutated in six out of the seven initial tumor specimens we sequenced," Yan said. "A mutation frequency of 85 percent is very high."The finding of two additional new genes involved in oligodendrogliomas increases the chances for an effective combination drug therapy for the tumor, Yan said. He envisions a combination cocktail of drugs similar to the combination-drug treatments taken by HIV patients that would target different pathways involved in cancer, and assist both in reducing the chance of relapsing and increasing odds of success.